2-(4-Oxoquinazolin-3(4H)-yl)acetic acid

Catalog No.: 
ACVXOC162
CAS No.: 
14663-53-7
Molecular Formula: 
C10H8N2O3
Molecular Weight: 
204.18
2-(4-Oxoquinazolin-3(4H)-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$63.00In stockIn stock
1g98%$97.00In stockIn stock
5g98%$389.00In stockIn stock
25g98%$1478.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Oxoquinazolin-3(4H)-yl)acetic acid
IUPAC Name2-(4-oxoquinazolin-3(4H)-yl)acetic acid
MDL No.MFCD02332713
Molecular FormulaC10H8N2O3
Molecular Weight204.18
SMILESOC(=O)CN1C=NC2=CC=CC=C2C1=O
InChI KeyBBBICQPTZBHLBM-UHFFFAOYSA-N
SynonymCHEMBRDG-BB 4001974;(4-OXO-4H-QUINAZOLIN-3-YL)-ACETIC ACID;(4-OXOQUINAZOLIN-3(4H)-YL)ACETIC ACID;AKOS BB69;ASISCHEM D51303;OTAVA-BB 7010160005;3(4H)-quinazolineacetic acid, 4-oxo-;(4-Oxo-3(4H)-quinazolinyl)acetic acid
CAS No.14663-53-7
PubChem CID729359

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVXOC162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXOC162 route product structure diagram
    ACVXOC16214663-53-7In Stock
Inquiry

2. ACVXOC162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXOC162 route product structure diagram
    ACVXOC16214663-53-7In Stock
Inquiry

3. ACVXOC162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXOC162 route product structure diagram
    ACVXOC16214663-53-7In Stock
Inquiry

Comments (0)